

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pre-miRNA processing (GO:0031054) | 5.37253993 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.88049992 |
| 3 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.53719770 |
| 4 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.53719770 |
| 5 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.53719770 |
| 6 | regulation of gene silencing by RNA (GO:0060966) | 4.23263202 |
| 7 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.23263202 |
| 8 | regulation of gene silencing by miRNA (GO:0060964) | 4.23263202 |
| 9 | negative regulation of histone methylation (GO:0031061) | 4.17930711 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00078905 |
| 11 | regulation of histone H3-K9 methylation (GO:0051570) | 3.94074387 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.89512395 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.89512395 |
| 14 | nuclear pore organization (GO:0006999) | 3.87872847 |
| 15 | leukocyte aggregation (GO:0070486) | 3.84103644 |
| 16 | heterochromatin organization (GO:0070828) | 3.71949448 |
| 17 | regulation of RIG-I signaling pathway (GO:0039535) | 3.66475958 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65659106 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.63131274 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.63068399 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60146550 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57136835 |
| 23 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.52510213 |
| 24 | regulation of DNA methylation (GO:0044030) | 3.48246746 |
| 25 | single strand break repair (GO:0000012) | 3.44106892 |
| 26 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.41136094 |
| 27 | negative regulation of phagocytosis (GO:0050765) | 3.38190162 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.34105152 |
| 29 | snRNA transcription (GO:0009301) | 3.24252964 |
| 30 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.21731565 |
| 31 | chromatin silencing (GO:0006342) | 3.16873465 |
| 32 | peptidyl-lysine trimethylation (GO:0018023) | 3.11692051 |
| 33 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.11526295 |
| 34 | histone H3-K9 methylation (GO:0051567) | 3.11030129 |
| 35 | histone H2B ubiquitination (GO:0033523) | 3.10511431 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.10023856 |
| 37 | behavioral response to nicotine (GO:0035095) | 3.08387013 |
| 38 | meiotic chromosome segregation (GO:0045132) | 3.07703262 |
| 39 | positive regulation of developmental pigmentation (GO:0048087) | 3.07115932 |
| 40 | chromatin assembly (GO:0031497) | 3.03885114 |
| 41 | paraxial mesoderm development (GO:0048339) | 3.03670918 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.03336633 |
| 43 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.03113462 |
| 44 | regulation of histone methylation (GO:0031060) | 3.03022048 |
| 45 | regulation of RNA export from nucleus (GO:0046831) | 3.01632423 |
| 46 | regulation of histone H3-K4 methylation (GO:0051569) | 3.01525750 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99770438 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99770438 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 2.99770438 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99770438 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 2.99770438 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99770438 |
| 53 | centriole replication (GO:0007099) | 2.97680580 |
| 54 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.97553153 |
| 55 | regulation of chromatin binding (GO:0035561) | 2.96832464 |
| 56 | negative T cell selection (GO:0043383) | 2.95002569 |
| 57 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.94141677 |
| 58 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.94141677 |
| 59 | positive regulation of histone methylation (GO:0031062) | 2.93502444 |
| 60 | regulation of B cell differentiation (GO:0045577) | 2.91990355 |
| 61 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.91431351 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 2.91181541 |
| 63 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.90078742 |
| 64 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.90078742 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89510460 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88562517 |
| 67 | negative thymic T cell selection (GO:0045060) | 2.85464577 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 2.85407362 |
| 69 | DNA topological change (GO:0006265) | 2.84672235 |
| 70 | ncRNA catabolic process (GO:0034661) | 2.83214796 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82281864 |
| 72 | DNA alkylation (GO:0006305) | 2.82207728 |
| 73 | DNA methylation (GO:0006306) | 2.82207728 |
| 74 | DNA replication checkpoint (GO:0000076) | 2.80016237 |
| 75 | definitive hemopoiesis (GO:0060216) | 2.79659135 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 2.78187037 |
| 77 | positive thymic T cell selection (GO:0045059) | 2.76701076 |
| 78 | response to peptidoglycan (GO:0032494) | 2.75416264 |
| 79 | regulation of centriole replication (GO:0046599) | 2.75261113 |
| 80 | histone H3-K36 demethylation (GO:0070544) | 2.75010360 |
| 81 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.74667515 |
| 82 | response to type I interferon (GO:0034340) | 2.73393154 |
| 83 | DNA damage induced protein phosphorylation (GO:0006975) | 2.68541938 |
| 84 | positive regulation of isotype switching (GO:0045830) | 2.68496740 |
| 85 | neuronal stem cell maintenance (GO:0097150) | 2.68312571 |
| 86 | positive regulation by host of viral transcription (GO:0043923) | 2.68121854 |
| 87 | regulation of centrosome duplication (GO:0010824) | 2.67579396 |
| 88 | regulation of gene silencing (GO:0060968) | 2.67500811 |
| 89 | type I interferon signaling pathway (GO:0060337) | 2.67411406 |
| 90 | cellular response to type I interferon (GO:0071357) | 2.67411406 |
| 91 | peptidyl-lysine methylation (GO:0018022) | 2.66271805 |
| 92 | histone H3-K9 modification (GO:0061647) | 2.65905234 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.64642546 |
| 94 | kidney morphogenesis (GO:0060993) | 2.64379317 |
| 95 | ATP-dependent chromatin remodeling (GO:0043044) | 2.64369880 |
| 96 | programmed necrotic cell death (GO:0097300) | 2.63918750 |
| 97 | regulation of growth hormone secretion (GO:0060123) | 2.63862320 |
| 98 | nonmotile primary cilium assembly (GO:0035058) | 2.63535277 |
| 99 | regulation of centrosome cycle (GO:0046605) | 2.62841897 |
| 100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62564143 |
| 101 | necrotic cell death (GO:0070265) | 2.60604354 |
| 102 | V(D)J recombination (GO:0033151) | 2.60307754 |
| 103 | chromatin remodeling at centromere (GO:0031055) | 2.59832609 |
| 104 | cell proliferation in forebrain (GO:0021846) | 2.59661411 |
| 105 | negative regulation of chromatin modification (GO:1903309) | 2.58530176 |
| 106 | tolerance induction (GO:0002507) | 2.57440323 |
| 107 | mitotic sister chromatid cohesion (GO:0007064) | 2.57223487 |
| 108 | presynaptic membrane organization (GO:0097090) | 2.55352457 |
| 109 | organ growth (GO:0035265) | 2.55194637 |
| 110 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.55045299 |
| 111 | genetic imprinting (GO:0071514) | 2.54561326 |
| 112 | determination of adult lifespan (GO:0008340) | 2.53702564 |
| 113 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.53633039 |
| 114 | cellular response to zinc ion (GO:0071294) | 2.52501498 |
| 115 | negative regulation of histone modification (GO:0031057) | 2.51789800 |
| 116 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.50409724 |
| 117 | regulation of gene expression by genetic imprinting (GO:0006349) | 2.50373064 |
| 118 | histone monoubiquitination (GO:0010390) | 2.49410010 |
| 119 | interferon-gamma production (GO:0032609) | 2.49203379 |
| 120 | dorsal/ventral axis specification (GO:0009950) | 2.48087265 |
| 121 | neutrophil activation (GO:0042119) | 2.47956421 |
| 122 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.46944573 |
| 123 | actin nucleation (GO:0045010) | 2.46512735 |
| 124 | T cell selection (GO:0045058) | 2.46343996 |
| 125 | prenylation (GO:0097354) | 2.45548796 |
| 126 | protein prenylation (GO:0018342) | 2.45548796 |
| 127 | forebrain neuron differentiation (GO:0021879) | 2.45404816 |
| 128 | neural tube formation (GO:0001841) | 2.45179830 |
| 129 | tongue development (GO:0043586) | 2.44721373 |
| 130 | regulation of helicase activity (GO:0051095) | 2.44343843 |
| 131 | positive T cell selection (GO:0043368) | 2.44033706 |
| 132 | regulation of stem cell maintenance (GO:2000036) | 2.43959025 |
| 133 | neutrophil mediated immunity (GO:0002446) | 2.43391935 |
| 134 | regulation of pigment cell differentiation (GO:0050932) | 2.43359451 |
| 135 | head development (GO:0060322) | 2.43285309 |
| 136 | hindbrain development (GO:0030902) | 2.43251956 |
| 137 | positive regulation of DNA recombination (GO:0045911) | 2.42542921 |
| 138 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.42324707 |
| 139 | necroptotic process (GO:0070266) | 2.42135444 |
| 140 | spinal cord development (GO:0021510) | 2.41935868 |
| 141 | hepatocyte apoptotic process (GO:0097284) | 2.41325361 |
| 142 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.41246429 |
| 143 | detection of molecule of bacterial origin (GO:0032490) | 2.39603314 |
| 144 | response to interleukin-15 (GO:0070672) | 2.39077708 |
| 145 | response to muramyl dipeptide (GO:0032495) | 2.39067906 |
| 146 | cellular extravasation (GO:0045123) | 2.38621828 |
| 147 | protein localization to chromosome, centromeric region (GO:0071459) | 2.38112290 |
| 148 | protein localization to kinetochore (GO:0034501) | 2.38100764 |
| 149 | reciprocal DNA recombination (GO:0035825) | 2.37256172 |
| 150 | reciprocal meiotic recombination (GO:0007131) | 2.37256172 |
| 151 | negative regulation of granulocyte differentiation (GO:0030853) | 2.36902307 |
| 152 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.36703571 |
| 153 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.35718593 |
| 154 | respiratory burst (GO:0045730) | 2.35504840 |
| 155 | nucleosome disassembly (GO:0006337) | 2.35306716 |
| 156 | protein-DNA complex disassembly (GO:0032986) | 2.35306716 |
| 157 | histone-serine phosphorylation (GO:0035404) | 2.34751628 |
| 158 | thymic T cell selection (GO:0045061) | 2.34555582 |
| 159 | CENP-A containing nucleosome assembly (GO:0034080) | 2.34516035 |
| 160 | dendritic cell chemotaxis (GO:0002407) | 2.34139341 |
| 161 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.33134068 |
| 162 | granulocyte activation (GO:0036230) | 2.31075571 |
| 163 | regulation of necroptotic process (GO:0060544) | 2.30813791 |
| 164 | dendritic cell migration (GO:0036336) | 2.30350174 |
| 165 | T cell lineage commitment (GO:0002360) | 2.27691208 |
| 166 | cellular response to virus (GO:0098586) | 2.27432093 |
| 167 | myeloid dendritic cell activation (GO:0001773) | 2.26175305 |
| 168 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.25370827 |
| 169 | leukocyte cell-cell adhesion (GO:0007159) | 2.24353031 |
| 170 | T-helper cell differentiation (GO:0042093) | 2.22420103 |
| 171 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.22420103 |
| 172 | positive regulation of humoral immune response (GO:0002922) | 2.22331940 |
| 173 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.22023227 |
| 174 | T cell migration (GO:0072678) | 2.21666769 |
| 175 | B cell homeostasis (GO:0001782) | 2.21304662 |
| 176 | regulation of DNA endoreduplication (GO:0032875) | 2.20199518 |
| 177 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.19996015 |
| 178 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.18758246 |
| 179 | positive regulation of B cell mediated immunity (GO:0002714) | 2.18758246 |
| 180 | daunorubicin metabolic process (GO:0044597) | 2.18594359 |
| 181 | polyketide metabolic process (GO:0030638) | 2.18594359 |
| 182 | doxorubicin metabolic process (GO:0044598) | 2.18594359 |
| 183 | defense response to protozoan (GO:0042832) | 2.18293284 |
| 184 | positive regulation of antigen processing and presentation (GO:0002579) | 2.18210124 |
| 185 | regulation of response to interferon-gamma (GO:0060330) | 2.17597532 |
| 186 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.17344283 |
| 187 | positive regulation of interferon-beta production (GO:0032728) | 2.17296628 |
| 188 | cellular response to interleukin-15 (GO:0071350) | 2.15793323 |
| 189 | negative regulation of B cell proliferation (GO:0030889) | 2.15055043 |
| 190 | lymphocyte homeostasis (GO:0002260) | 2.14775480 |
| 191 | T cell homeostasis (GO:0043029) | 2.14632112 |
| 192 | nuclear pore complex assembly (GO:0051292) | 2.14512586 |
| 193 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.13403089 |
| 194 | pore complex assembly (GO:0046931) | 2.13338351 |
| 195 | B cell mediated immunity (GO:0019724) | 2.12228204 |
| 196 | positive regulation of B cell activation (GO:0050871) | 2.11416674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.23209603 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77248065 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.73080213 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.40251165 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.83376972 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.73062486 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72463186 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.61646626 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.40418834 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35207808 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26048149 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88148966 |
| 13 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.63841606 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.57923524 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56969462 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54456530 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.43872242 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40141023 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.37617384 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32660234 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 2.31612887 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29305806 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28668410 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.24944667 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.23205452 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21544128 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.20711382 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15664828 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12546024 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11794015 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11442989 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10618842 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07262220 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02223387 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00068241 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99905478 |
| 37 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.99905478 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97118138 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.97087372 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94374117 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.92387004 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.88298345 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.86963907 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86564118 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84001834 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80720206 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79624536 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76233144 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72439612 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70928742 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.70250568 |
| 52 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.65682074 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.64118023 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62988174 |
| 55 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.61748175 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61084736 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57888025 |
| 58 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.57799293 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53086543 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51965908 |
| 61 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.48220837 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46987723 |
| 63 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.46509709 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.44789201 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42633422 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41063680 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41043984 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40819401 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40046290 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39934380 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39869922 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38759457 |
| 73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38604108 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37845294 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.36620837 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36208851 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34645355 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34397803 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33788316 |
| 80 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.33657229 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33483772 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32284568 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31015104 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30550359 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30087909 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27921477 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26634678 |
| 88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26083427 |
| 89 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25992525 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25349138 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25329358 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24743973 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24598555 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24036186 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.23571401 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23413571 |
| 97 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22975357 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22168024 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20690370 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20464467 |
| 101 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20448655 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18999550 |
| 103 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18787091 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18404284 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17734158 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17371234 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15610842 |
| 108 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14758002 |
| 109 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13214302 |
| 110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12265921 |
| 111 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11593185 |
| 112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11486206 |
| 113 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.11237195 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11040369 |
| 115 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10170189 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09621838 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09168539 |
| 118 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09090931 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08626035 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08341569 |
| 121 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07697019 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07337478 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07310384 |
| 124 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07265226 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06700661 |
| 126 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.05713810 |
| 127 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04427838 |
| 128 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.04373107 |
| 129 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03993488 |
| 130 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02173620 |
| 131 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.00630371 |
| 132 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00580606 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00184658 |
| 134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99682329 |
| 135 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98749473 |
| 136 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98306587 |
| 137 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98287194 |
| 138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98123847 |
| 139 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97524193 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97511623 |
| 141 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97250301 |
| 142 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97250301 |
| 143 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96810617 |
| 144 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96712897 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96702463 |
| 146 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.96477419 |
| 147 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96271612 |
| 148 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95480399 |
| 149 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95122122 |
| 150 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95027331 |
| 151 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95010713 |
| 152 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.94478827 |
| 153 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93625700 |
| 154 | AR_19668381_ChIP-Seq_PC3_Human | 0.93587577 |
| 155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92874650 |
| 156 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92833944 |
| 157 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91111943 |
| 158 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90403843 |
| 159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90372101 |
| 160 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90298113 |
| 161 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90272509 |
| 162 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89938973 |
| 163 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.89535202 |
| 164 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88789790 |
| 165 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88539076 |
| 166 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88232782 |
| 167 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.88040804 |
| 168 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87448902 |
| 169 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87247544 |
| 170 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86558045 |
| 171 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86540591 |
| 172 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.86425799 |
| 173 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85198128 |
| 174 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84621010 |
| 175 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84050708 |
| 176 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83744860 |
| 177 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83016529 |
| 178 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82929014 |
| 179 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82803655 |
| 180 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82320196 |
| 181 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.81943058 |
| 182 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81020607 |
| 183 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80922325 |
| 184 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80612830 |
| 185 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.80539785 |
| 186 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79630379 |
| 187 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77907407 |
| 188 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77672141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003890_abnormal_embryonic-extraembry | 4.04130741 |
| 2 | MP0003136_yellow_coat_color | 3.42935477 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.21402571 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.16552523 |
| 5 | MP0008877_abnormal_DNA_methylation | 2.71356945 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.63994760 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.60645466 |
| 8 | MP0005671_abnormal_response_to | 2.36833052 |
| 9 | MP0001800_abnormal_humoral_immune | 2.30733606 |
| 10 | MP0009785_altered_susceptibility_to | 2.29889014 |
| 11 | MP0003119_abnormal_digestive_system | 2.25326100 |
| 12 | MP0003436_decreased_susceptibility_to | 2.17033174 |
| 13 | MP0003121_genomic_imprinting | 2.15477902 |
| 14 | MP0005387_immune_system_phenotype | 2.13122813 |
| 15 | MP0001790_abnormal_immune_system | 2.13122813 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.04567035 |
| 17 | MP0001293_anophthalmia | 2.04341878 |
| 18 | MP0002419_abnormal_innate_immunity | 2.00394870 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.99293965 |
| 20 | MP0002723_abnormal_immune_serum | 1.96878901 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.95889820 |
| 22 | MP0005025_abnormal_response_to | 1.93711655 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.91722891 |
| 24 | MP0003937_abnormal_limbs/digits/tail_de | 1.90956560 |
| 25 | MP0001819_abnormal_immune_cell | 1.90756396 |
| 26 | MP0005360_urolithiasis | 1.90752383 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.90513818 |
| 28 | MP0005365_abnormal_bile_salt | 1.82541847 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.82422357 |
| 30 | MP0002398_abnormal_bone_marrow | 1.81361093 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.81290094 |
| 32 | MP0000778_abnormal_nervous_system | 1.80090401 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.79917647 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.78121209 |
| 35 | MP0003123_paternal_imprinting | 1.76274956 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.75480696 |
| 37 | MP0003122_maternal_imprinting | 1.71351821 |
| 38 | MP0002006_tumorigenesis | 1.69474281 |
| 39 | MP0000685_abnormal_immune_system | 1.69169464 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.67252660 |
| 41 | MP0000716_abnormal_immune_system | 1.65122749 |
| 42 | MP0002405_respiratory_system_inflammati | 1.64790956 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.61711846 |
| 44 | MP0000631_abnormal_neuroendocrine_gland | 1.61346206 |
| 45 | MP0001873_stomach_inflammation | 1.60114551 |
| 46 | MP0003724_increased_susceptibility_to | 1.59335190 |
| 47 | MP0002084_abnormal_developmental_patter | 1.56679860 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.54499482 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.54039999 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.52445103 |
| 51 | MP0005499_abnormal_olfactory_system | 1.51832033 |
| 52 | MP0005394_taste/olfaction_phenotype | 1.51832033 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.51032450 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.51032450 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 1.49934165 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.49212501 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.48865572 |
| 58 | MP0002132_abnormal_respiratory_system | 1.46035180 |
| 59 | MP0000427_abnormal_hair_cycle | 1.44470574 |
| 60 | MP0003646_muscle_fatigue | 1.43501901 |
| 61 | MP0006082_CNS_inflammation | 1.43491420 |
| 62 | MP0001286_abnormal_eye_development | 1.43316366 |
| 63 | MP0004947_skin_inflammation | 1.43104922 |
| 64 | MP0003252_abnormal_bile_duct | 1.42685118 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.42266807 |
| 66 | MP0001853_heart_inflammation | 1.41672464 |
| 67 | MP0000490_abnormal_crypts_of | 1.41355568 |
| 68 | MP0002697_abnormal_eye_size | 1.40843816 |
| 69 | MP0002429_abnormal_blood_cell | 1.40415424 |
| 70 | MP0003693_abnormal_embryo_hatching | 1.39307490 |
| 71 | MP0002722_abnormal_immune_system | 1.37841911 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.36992538 |
| 73 | MP0003861_abnormal_nervous_system | 1.35627193 |
| 74 | MP0008057_abnormal_DNA_replication | 1.35551052 |
| 75 | MP0004197_abnormal_fetal_growth/weight/ | 1.35139130 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.33336093 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 1.31682464 |
| 78 | MP0008058_abnormal_DNA_repair | 1.31352026 |
| 79 | MP0003718_maternal_effect | 1.31133066 |
| 80 | MP0005380_embryogenesis_phenotype | 1.29887086 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 1.29887086 |
| 82 | MP0008932_abnormal_embryonic_tissue | 1.29278234 |
| 83 | MP0008469_abnormal_protein_level | 1.28811998 |
| 84 | MP0000383_abnormal_hair_follicle | 1.26660614 |
| 85 | MP0009672_abnormal_birth_weight | 1.26355052 |
| 86 | MP0002085_abnormal_embryonic_tissue | 1.25813173 |
| 87 | MP0001764_abnormal_homeostasis | 1.25428287 |
| 88 | MP0000703_abnormal_thymus_morphology | 1.24745950 |
| 89 | MP0003303_peritoneal_inflammation | 1.24692465 |
| 90 | MP0002233_abnormal_nose_morphology | 1.23380825 |
| 91 | MP0005409_darkened_coat_color | 1.21476487 |
| 92 | MP0001188_hyperpigmentation | 1.20870715 |
| 93 | MP0003984_embryonic_growth_retardation | 1.20794230 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 1.20583281 |
| 95 | MP0002088_abnormal_embryonic_growth/wei | 1.19564156 |
| 96 | MP0002092_abnormal_eye_morphology | 1.16749005 |
| 97 | MP0001697_abnormal_embryo_size | 1.15235969 |
| 98 | MP0009764_decreased_sensitivity_to | 1.14619582 |
| 99 | MP0001730_embryonic_growth_arrest | 1.13918848 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 1.13695344 |
| 101 | MP0008961_abnormal_basal_metabolism | 1.13403118 |
| 102 | MP0002751_abnormal_autonomic_nervous | 1.12279752 |
| 103 | MP0001851_eye_inflammation | 1.12076780 |
| 104 | MP0000858_altered_metastatic_potential | 1.11249695 |
| 105 | MP0009697_abnormal_copulation | 1.09697252 |
| 106 | MP0003935_abnormal_craniofacial_develop | 1.09433419 |
| 107 | MP0005310_abnormal_salivary_gland | 1.09292278 |
| 108 | MP0000428_abnormal_craniofacial_morphol | 1.08975438 |
| 109 | MP0003941_abnormal_skin_development | 1.08088498 |
| 110 | MP0004133_heterotaxia | 1.07516374 |
| 111 | MP0005174_abnormal_tail_pigmentation | 1.07397086 |
| 112 | MP0010678_abnormal_skin_adnexa | 1.06778423 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 1.06531358 |
| 114 | MP0008995_early_reproductive_senescence | 1.03147696 |
| 115 | MP0003183_abnormal_peptide_metabolism | 1.01812095 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 1.01565827 |
| 117 | MP0001533_abnormal_skeleton_physiology | 1.01006128 |
| 118 | MP0005187_abnormal_penis_morphology | 1.00916982 |
| 119 | MP0003938_abnormal_ear_development | 0.98932247 |
| 120 | MP0002160_abnormal_reproductive_system | 0.98559888 |
| 121 | MP0003011_delayed_dark_adaptation | 0.98444548 |
| 122 | MP0003755_abnormal_palate_morphology | 0.98337680 |
| 123 | MP0009703_decreased_birth_body | 0.97488393 |
| 124 | MP0002938_white_spotting | 0.96792982 |
| 125 | MP0009763_increased_sensitivity_to | 0.96181520 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.95651063 |
| 127 | MP0002009_preneoplasia | 0.95596463 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.95177369 |
| 129 | MP0003115_abnormal_respiratory_system | 0.94776583 |
| 130 | MP0002111_abnormal_tail_morphology | 0.94741920 |
| 131 | MP0000350_abnormal_cell_proliferation | 0.94305812 |
| 132 | MP0002210_abnormal_sex_determination | 0.93805201 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.92838870 |
| 134 | MP0003942_abnormal_urinary_system | 0.92692374 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.91955284 |
| 136 | MP0006054_spinal_hemorrhage | 0.91421496 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.90820481 |
| 138 | MP0005391_vision/eye_phenotype | 0.90377439 |
| 139 | MP0000609_abnormal_liver_physiology | 0.89852953 |
| 140 | MP0002277_abnormal_respiratory_mucosa | 0.89737427 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.88389884 |
| 142 | MP0001666_abnormal_nutrient_absorption | 0.88198863 |
| 143 | MP0003077_abnormal_cell_cycle | 0.87937482 |
| 144 | MP0005389_reproductive_system_phenotype | 0.87358724 |
| 145 | MP0001929_abnormal_gametogenesis | 0.86473577 |
| 146 | MP0002081_perinatal_lethality | 0.85895341 |
| 147 | MP0003950_abnormal_plasma_membrane | 0.85251362 |
| 148 | MP0010352_gastrointestinal_tract_polyps | 0.85136922 |
| 149 | MP0002152_abnormal_brain_morphology | 0.84521111 |
| 150 | MP0003656_abnormal_erythrocyte_physiolo | 0.83835745 |
| 151 | MP0003448_altered_tumor_morphology | 0.83818401 |
| 152 | MP0001324_abnormal_eye_pigmentation | 0.82688905 |
| 153 | MP0002089_abnormal_postnatal_growth/wei | 0.81408703 |
| 154 | MP0010307_abnormal_tumor_latency | 0.81286630 |
| 155 | MP0005408_hypopigmentation | 0.80938809 |
| 156 | MP0002075_abnormal_coat/hair_pigmentati | 0.79492860 |
| 157 | MP0002928_abnormal_bile_duct | 0.79392429 |
| 158 | MP0001919_abnormal_reproductive_system | 0.79003253 |
| 159 | MP0003385_abnormal_body_wall | 0.78847230 |
| 160 | MP0000955_abnormal_spinal_cord | 0.78015330 |
| 161 | MP0005220_abnormal_exocrine_pancreas | 0.77853172 |
| 162 | MP0000432_abnormal_head_morphology | 0.77029507 |
| 163 | MP0000647_abnormal_sebaceous_gland | 0.76683854 |
| 164 | MP0003111_abnormal_nucleus_morphology | 0.76625393 |
| 165 | MP0002998_abnormal_bone_remodeling | 0.76581915 |
| 166 | MP0002184_abnormal_innervation | 0.76028639 |
| 167 | MP0002234_abnormal_pharynx_morphology | 0.75778269 |
| 168 | MP0000579_abnormal_nail_morphology | 0.75140651 |
| 169 | MP0002752_abnormal_somatic_nervous | 0.75104649 |
| 170 | MP0009278_abnormal_bone_marrow | 0.75098015 |
| 171 | MP0003191_abnormal_cellular_cholesterol | 0.74714339 |
| 172 | MP0003787_abnormal_imprinting | 0.74463995 |
| 173 | MP0003315_abnormal_perineum_morphology | 0.74098252 |
| 174 | MP0002086_abnormal_extraembryonic_tissu | 0.74046684 |
| 175 | MP0000566_synostosis | 0.73806217 |
| 176 | MP0005195_abnormal_posterior_eye | 0.73467990 |
| 177 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72531253 |
| 178 | MP0003866_abnormal_defecation | 0.70743650 |
| 179 | MP0001915_intracranial_hemorrhage | 0.70184687 |
| 180 | MP0000598_abnormal_liver_morphology | 0.69551138 |
| 181 | MP0002136_abnormal_kidney_physiology | 0.68416716 |
| 182 | MP0002095_abnormal_skin_pigmentation | 0.67799629 |
| 183 | MP0009765_abnormal_xenobiotic_induced | 0.67596868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatoblastoma (HP:0002884) | 4.41837778 |
| 2 | Abnormality of the fingertips (HP:0001211) | 4.10578062 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.02515926 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.87949222 |
| 5 | Colon cancer (HP:0003003) | 3.71299527 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.53841659 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43549109 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.38528347 |
| 9 | Pigmentary retinal degeneration (HP:0001146) | 3.32386240 |
| 10 | Neoplasm of the adrenal cortex (HP:0100641) | 3.31916336 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.28918097 |
| 12 | IgM deficiency (HP:0002850) | 3.26430463 |
| 13 | Recurrent viral infections (HP:0004429) | 3.21484312 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.14362237 |
| 15 | T lymphocytopenia (HP:0005403) | 3.11573797 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.04798406 |
| 17 | Chromsome breakage (HP:0040012) | 2.95278640 |
| 18 | Recurrent bronchitis (HP:0002837) | 2.88769481 |
| 19 | B lymphocytopenia (HP:0010976) | 2.79410823 |
| 20 | Abnormality of B cell number (HP:0010975) | 2.79410823 |
| 21 | Agammaglobulinemia (HP:0004432) | 2.68089936 |
| 22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.68035910 |
| 23 | Chronic diarrhea (HP:0002028) | 2.67296649 |
| 24 | Chronic otitis media (HP:0000389) | 2.66795240 |
| 25 | Septo-optic dysplasia (HP:0100842) | 2.57609532 |
| 26 | Eosinophilia (HP:0001880) | 2.56684902 |
| 27 | Meningitis (HP:0001287) | 2.55415895 |
| 28 | Abnormality of T cells (HP:0002843) | 2.54205582 |
| 29 | Abnormality of the prostate (HP:0008775) | 2.53378303 |
| 30 | Reticulocytopenia (HP:0001896) | 2.52891950 |
| 31 | Volvulus (HP:0002580) | 2.52600328 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.51950655 |
| 33 | Recurrent skin infections (HP:0001581) | 2.50193546 |
| 34 | High anterior hairline (HP:0009890) | 2.49933195 |
| 35 | Lymphopenia (HP:0001888) | 2.49319033 |
| 36 | Protruding tongue (HP:0010808) | 2.49299152 |
| 37 | Drooling (HP:0002307) | 2.48444532 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.47903964 |
| 39 | Lip pit (HP:0100267) | 2.47779912 |
| 40 | Periodontitis (HP:0000704) | 2.45931112 |
| 41 | Diastasis recti (HP:0001540) | 2.44311154 |
| 42 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.42606150 |
| 43 | Myositis (HP:0100614) | 2.41420962 |
| 44 | IgA deficiency (HP:0002720) | 2.41321601 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40250723 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40250723 |
| 47 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.38888683 |
| 48 | Gingivitis (HP:0000230) | 2.38492156 |
| 49 | Hypoplastic labia majora (HP:0000059) | 2.38013510 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37066482 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.36789965 |
| 52 | Hypophosphatemic rickets (HP:0004912) | 2.36220403 |
| 53 | Abnormality of the labia minora (HP:0012880) | 2.35766854 |
| 54 | Acute myeloid leukemia (HP:0004808) | 2.34864042 |
| 55 | Encephalitis (HP:0002383) | 2.33841596 |
| 56 | Impulsivity (HP:0100710) | 2.33830237 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.32962568 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32538646 |
| 59 | Long eyelashes (HP:0000527) | 2.29768530 |
| 60 | Excessive salivation (HP:0003781) | 2.29482509 |
| 61 | Embryonal renal neoplasm (HP:0011794) | 2.29333890 |
| 62 | Ectopic kidney (HP:0000086) | 2.28318048 |
| 63 | Pustule (HP:0200039) | 2.27787543 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.27705532 |
| 65 | Thyroiditis (HP:0100646) | 2.26962890 |
| 66 | Vasculitis (HP:0002633) | 2.25828519 |
| 67 | Abnormality of the labia majora (HP:0012881) | 2.25590495 |
| 68 | Patellar aplasia (HP:0006443) | 2.24012466 |
| 69 | Granulocytopenia (HP:0001913) | 2.20624027 |
| 70 | Esophageal atresia (HP:0002032) | 2.19473915 |
| 71 | Osteomyelitis (HP:0002754) | 2.18750251 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.18040673 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.17608909 |
| 74 | Abnormality of T cell physiology (HP:0011840) | 2.17318542 |
| 75 | Truncal obesity (HP:0001956) | 2.16130104 |
| 76 | Medulloblastoma (HP:0002885) | 2.15913424 |
| 77 | Recurrent pneumonia (HP:0006532) | 2.15768119 |
| 78 | Severe combined immunodeficiency (HP:0004430) | 2.15751890 |
| 79 | Pancreatic cysts (HP:0001737) | 2.14567345 |
| 80 | Papillary thyroid carcinoma (HP:0002895) | 2.12983367 |
| 81 | Facial hemangioma (HP:0000329) | 2.12934861 |
| 82 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.11375642 |
| 83 | Meckel diverticulum (HP:0002245) | 2.10952075 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.09898728 |
| 85 | Chorioretinal atrophy (HP:0000533) | 2.09122116 |
| 86 | Gastrointestinal carcinoma (HP:0002672) | 2.08787270 |
| 87 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.08787270 |
| 88 | Obstructive lung disease (HP:0006536) | 2.08278576 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08278576 |
| 90 | Gingival bleeding (HP:0000225) | 2.07621349 |
| 91 | Thrombocytosis (HP:0001894) | 2.06695101 |
| 92 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06472191 |
| 93 | Missing ribs (HP:0000921) | 2.05862054 |
| 94 | Cellulitis (HP:0100658) | 2.05065763 |
| 95 | Leukocytosis (HP:0001974) | 2.04624757 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.04036178 |
| 97 | Rib fusion (HP:0000902) | 2.03458608 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.03171339 |
| 99 | IgG deficiency (HP:0004315) | 2.02942837 |
| 100 | Leiomyosarcoma (HP:0100243) | 2.02600084 |
| 101 | Uterine leiomyosarcoma (HP:0002891) | 2.02600084 |
| 102 | Pendular nystagmus (HP:0012043) | 2.02441132 |
| 103 | Chronic hepatic failure (HP:0100626) | 2.02405450 |
| 104 | Obsessive-compulsive behavior (HP:0000722) | 2.01699745 |
| 105 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01585072 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 1.99875476 |
| 107 | Combined immunodeficiency (HP:0005387) | 1.99369672 |
| 108 | Retrobulbar optic neuritis (HP:0100654) | 1.99214115 |
| 109 | Optic neuritis (HP:0100653) | 1.99214115 |
| 110 | Arterial thrombosis (HP:0004420) | 1.98485610 |
| 111 | Abnormality of the ileum (HP:0001549) | 1.98406144 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 1.98307496 |
| 113 | Joint hemorrhage (HP:0005261) | 1.97707742 |
| 114 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.96991817 |
| 115 | Anophthalmia (HP:0000528) | 1.96838163 |
| 116 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96606147 |
| 117 | Abnormality of the septum pellucidum (HP:0007375) | 1.95323312 |
| 118 | Pancreatic fibrosis (HP:0100732) | 1.95316071 |
| 119 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.95219899 |
| 120 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.94881239 |
| 121 | Increased IgE level (HP:0003212) | 1.94846268 |
| 122 | Aqueductal stenosis (HP:0002410) | 1.94747184 |
| 123 | Birth length less than 3rd percentile (HP:0003561) | 1.94719551 |
| 124 | Rhabdomyosarcoma (HP:0002859) | 1.93737931 |
| 125 | Hypoplasia of the thymus (HP:0000778) | 1.93398667 |
| 126 | Bladder carcinoma (HP:0002862) | 1.93165216 |
| 127 | Bladder neoplasm (HP:0009725) | 1.93165216 |
| 128 | Orchitis (HP:0100796) | 1.92650552 |
| 129 | Heterotopia (HP:0002282) | 1.92259480 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.91882435 |
| 131 | Cortical dysplasia (HP:0002539) | 1.91155617 |
| 132 | Bilateral microphthalmos (HP:0007633) | 1.90779198 |
| 133 | Neonatal hypoglycemia (HP:0001998) | 1.89009479 |
| 134 | Prostate neoplasm (HP:0100787) | 1.88487318 |
| 135 | Limb hypertonia (HP:0002509) | 1.88352126 |
| 136 | Oligodactyly (hands) (HP:0001180) | 1.88271191 |
| 137 | Stomatitis (HP:0010280) | 1.88059517 |
| 138 | Cheilitis (HP:0100825) | 1.87296512 |
| 139 | Tubular atrophy (HP:0000092) | 1.87210386 |
| 140 | Fair hair (HP:0002286) | 1.87127347 |
| 141 | Absent thumb (HP:0009777) | 1.86929094 |
| 142 | Supernumerary spleens (HP:0009799) | 1.86657430 |
| 143 | Partial agenesis of the corpus callosum (HP:0001338) | 1.86642923 |
| 144 | Keratitis (HP:0000491) | 1.86564424 |
| 145 | Sloping forehead (HP:0000340) | 1.86244200 |
| 146 | Epistaxis (HP:0000421) | 1.86021848 |
| 147 | Abnormality of the carotid arteries (HP:0005344) | 1.85641552 |
| 148 | Abnormality of chromosome segregation (HP:0002916) | 1.85340460 |
| 149 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84756222 |
| 150 | Labial hypoplasia (HP:0000066) | 1.83946608 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.83278911 |
| 152 | Keratoconjunctivitis (HP:0001096) | 1.83191016 |
| 153 | Abnormality of DNA repair (HP:0003254) | 1.83044808 |
| 154 | Fat malabsorption (HP:0002630) | 1.82921220 |
| 155 | Steatorrhea (HP:0002570) | 1.82910011 |
| 156 | Scrotal hypoplasia (HP:0000046) | 1.82487925 |
| 157 | Abnormality of the renal cortex (HP:0011035) | 1.81532446 |
| 158 | Growth hormone deficiency (HP:0000824) | 1.80622114 |
| 159 | Acute lymphatic leukemia (HP:0006721) | 1.78970705 |
| 160 | Increased mean platelet volume (HP:0011877) | 1.78169179 |
| 161 | Biliary tract neoplasm (HP:0100574) | 1.78050133 |
| 162 | Colitis (HP:0002583) | 1.77402752 |
| 163 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77266210 |
| 164 | Intestinal atresia (HP:0011100) | 1.77138425 |
| 165 | Pulmonary infiltrates (HP:0002113) | 1.76596584 |
| 166 | Recurrent lower respiratory tract infections (HP:0002783) | 1.75865207 |
| 167 | Gastrointestinal stroma tumor (HP:0100723) | 1.75608537 |
| 168 | Dandy-Walker malformation (HP:0001305) | 1.75378266 |
| 169 | Abnormality of chromosome stability (HP:0003220) | 1.74950072 |
| 170 | Stomach cancer (HP:0012126) | 1.73297542 |
| 171 | 11 pairs of ribs (HP:0000878) | 1.73159122 |
| 172 | Sandal gap (HP:0001852) | 1.72948448 |
| 173 | Osteomalacia (HP:0002749) | 1.72595735 |
| 174 | Anencephaly (HP:0002323) | 1.72302176 |
| 175 | Abnormal number of erythroid precursors (HP:0012131) | 1.71783503 |
| 176 | Deep palmar crease (HP:0006191) | 1.71777265 |
| 177 | Triphalangeal thumb (HP:0001199) | 1.71073581 |
| 178 | Renovascular hypertension (HP:0100817) | 1.71003333 |
| 179 | Nephronophthisis (HP:0000090) | 1.69883090 |
| 180 | Neoplasm of the liver (HP:0002896) | 1.69747717 |
| 181 | Absent septum pellucidum (HP:0001331) | 1.69381818 |
| 182 | Hypoplastic female external genitalia (HP:0012815) | 1.67959366 |
| 183 | Poikiloderma (HP:0001029) | 1.66116827 |
| 184 | Abnormality of the aortic arch (HP:0012303) | 1.65862806 |
| 185 | Spina bifida occulta (HP:0003298) | 1.65407352 |
| 186 | Optic nerve hypoplasia (HP:0000609) | 1.64738054 |
| 187 | Thyroid carcinoma (HP:0002890) | 1.64438052 |
| 188 | Abnormality of the preputium (HP:0100587) | 1.63874366 |
| 189 | Intestinal fistula (HP:0100819) | 1.63159923 |
| 190 | Embryonal neoplasm (HP:0002898) | 1.62590826 |
| 191 | Abnormal biliary tract physiology (HP:0012439) | 1.62333121 |
| 192 | Bile duct proliferation (HP:0001408) | 1.62333121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.21711288 |
| 2 | MAP3K14 | 3.05838957 |
| 3 | TXK | 2.99636848 |
| 4 | CASK | 2.91603277 |
| 5 | IRAK4 | 2.91557082 |
| 6 | MAP3K4 | 2.78900585 |
| 7 | IRAK3 | 2.52921727 |
| 8 | WNK3 | 2.50903782 |
| 9 | JAK3 | 2.41460795 |
| 10 | TYK2 | 2.22272156 |
| 11 | TAOK3 | 2.18913965 |
| 12 | CAMK1G | 2.18432677 |
| 13 | IKBKE | 2.13990965 |
| 14 | TEC | 2.12622999 |
| 15 | RPS6KA4 | 2.11125062 |
| 16 | FGFR2 | 1.99224112 |
| 17 | CDK12 | 1.89777216 |
| 18 | NEK9 | 1.84561720 |
| 19 | STK38L | 1.84443200 |
| 20 | ICK | 1.70857836 |
| 21 | STK10 | 1.70708859 |
| 22 | ITK | 1.66210768 |
| 23 | JAK1 | 1.64845417 |
| 24 | BTK | 1.64204245 |
| 25 | SIK3 | 1.63777859 |
| 26 | MAP2K7 | 1.61827496 |
| 27 | CDC7 | 1.61320918 |
| 28 | BRD4 | 1.58152169 |
| 29 | TBK1 | 1.57263116 |
| 30 | CHUK | 1.56132677 |
| 31 | BMPR1B | 1.52943649 |
| 32 | PNCK | 1.52734362 |
| 33 | IKBKB | 1.51335096 |
| 34 | WNK4 | 1.51075667 |
| 35 | EEF2K | 1.51068135 |
| 36 | TAF1 | 1.46439077 |
| 37 | ZAP70 | 1.45892496 |
| 38 | TTK | 1.43851845 |
| 39 | CLK1 | 1.41690787 |
| 40 | DYRK3 | 1.41002022 |
| 41 | FGFR3 | 1.40755251 |
| 42 | WNK1 | 1.40031798 |
| 43 | KIT | 1.39840308 |
| 44 | PIM1 | 1.38713083 |
| 45 | ERN1 | 1.38661749 |
| 46 | TYRO3 | 1.36451632 |
| 47 | BLK | 1.34704167 |
| 48 | FGFR4 | 1.34246010 |
| 49 | BRSK2 | 1.33305770 |
| 50 | MAP2K4 | 1.25669013 |
| 51 | CHEK2 | 1.25425741 |
| 52 | TGFBR2 | 1.21831539 |
| 53 | INSRR | 1.21025917 |
| 54 | CSF1R | 1.19524262 |
| 55 | MAP3K10 | 1.15188616 |
| 56 | ZAK | 1.14438523 |
| 57 | YES1 | 1.14021818 |
| 58 | SIK1 | 1.12866911 |
| 59 | NLK | 1.12592738 |
| 60 | SGK2 | 1.08973389 |
| 61 | MAP3K9 | 1.08522999 |
| 62 | TNIK | 1.08245989 |
| 63 | STK4 | 1.06203896 |
| 64 | MAP2K3 | 1.06078602 |
| 65 | CSK | 1.05850804 |
| 66 | TRPM7 | 1.05736908 |
| 67 | TLK1 | 1.05455642 |
| 68 | MARK3 | 1.05151365 |
| 69 | MAP3K6 | 1.02977739 |
| 70 | NEK2 | 0.98699339 |
| 71 | NUAK1 | 0.98529452 |
| 72 | PLK4 | 0.97579868 |
| 73 | SGK3 | 0.96494991 |
| 74 | SYK | 0.95068126 |
| 75 | TNK2 | 0.94997881 |
| 76 | RPS6KB2 | 0.94383722 |
| 77 | FRK | 0.94073687 |
| 78 | ATR | 0.93097166 |
| 79 | ACVR1B | 0.85201317 |
| 80 | PASK | 0.85166540 |
| 81 | FLT3 | 0.84239702 |
| 82 | VRK1 | 0.83444460 |
| 83 | LCK | 0.82291318 |
| 84 | LATS2 | 0.79498228 |
| 85 | STK3 | 0.77437965 |
| 86 | EPHA3 | 0.76547541 |
| 87 | HCK | 0.75691055 |
| 88 | GRK1 | 0.75376850 |
| 89 | STK11 | 0.73605938 |
| 90 | IRAK1 | 0.72006591 |
| 91 | ERBB3 | 0.71632960 |
| 92 | MKNK1 | 0.71566387 |
| 93 | RPS6KA5 | 0.71304358 |
| 94 | PLK1 | 0.69683132 |
| 95 | SGK494 | 0.69287718 |
| 96 | SGK223 | 0.69287718 |
| 97 | CSNK1E | 0.69279205 |
| 98 | PLK3 | 0.69198910 |
| 99 | CDK3 | 0.68434796 |
| 100 | AKT3 | 0.67878435 |
| 101 | LYN | 0.65555641 |
| 102 | STK39 | 0.65498298 |
| 103 | LATS1 | 0.65486361 |
| 104 | MAP3K3 | 0.64782286 |
| 105 | CHEK1 | 0.64756174 |
| 106 | CDK2 | 0.64731019 |
| 107 | WEE1 | 0.64080726 |
| 108 | MKNK2 | 0.63452558 |
| 109 | JAK2 | 0.63400310 |
| 110 | MAPK11 | 0.61437768 |
| 111 | DYRK1B | 0.60675267 |
| 112 | FGFR1 | 0.60250066 |
| 113 | CDK1 | 0.57782106 |
| 114 | EIF2AK3 | 0.57260865 |
| 115 | EIF2AK2 | 0.57216767 |
| 116 | PRKCQ | 0.56775148 |
| 117 | TGFBR1 | 0.54256593 |
| 118 | RPS6KA6 | 0.54245367 |
| 119 | SRPK1 | 0.52689156 |
| 120 | STK16 | 0.51897776 |
| 121 | DMPK | 0.51146674 |
| 122 | EPHB1 | 0.50951464 |
| 123 | CDK7 | 0.50838262 |
| 124 | LRRK2 | 0.50255403 |
| 125 | SIK2 | 0.50141501 |
| 126 | CDK6 | 0.49332911 |
| 127 | RPS6KL1 | 0.49219395 |
| 128 | RPS6KC1 | 0.49219395 |
| 129 | DYRK2 | 0.48961473 |
| 130 | PBK | 0.48830996 |
| 131 | CSNK1A1L | 0.48464998 |
| 132 | MTOR | 0.47988199 |
| 133 | PDGFRA | 0.47613962 |
| 134 | CDK8 | 0.47566183 |
| 135 | GSK3B | 0.47439727 |
| 136 | CSNK1D | 0.47286979 |
| 137 | TAOK2 | 0.46958099 |
| 138 | BMPR2 | 0.46646745 |
| 139 | MAP3K5 | 0.46316928 |
| 140 | TSSK6 | 0.44165017 |
| 141 | CSNK1G1 | 0.44034416 |
| 142 | CDK4 | 0.43752257 |
| 143 | MAPK14 | 0.43094493 |
| 144 | PRKCH | 0.42162560 |
| 145 | AKT1 | 0.41801906 |
| 146 | RPS6KB1 | 0.41358115 |
| 147 | CAMK1D | 0.41265586 |
| 148 | ATM | 0.41219795 |
| 149 | MARK2 | 0.41130486 |
| 150 | DYRK1A | 0.41028123 |
| 151 | PRKDC | 0.40952198 |
| 152 | MAPK8 | 0.40001738 |
| 153 | PTK6 | 0.39796077 |
| 154 | ALK | 0.39170998 |
| 155 | HIPK2 | 0.38052125 |
| 156 | PDGFRB | 0.37748101 |
| 157 | MELK | 0.37239487 |
| 158 | NME1 | 0.36586839 |
| 159 | PRKAA2 | 0.36569889 |
| 160 | ABL1 | 0.36342903 |
| 161 | CAMK4 | 0.36146831 |
| 162 | MAP3K13 | 0.36091151 |
| 163 | GRK6 | 0.35562252 |
| 164 | PIK3CA | 0.35419658 |
| 165 | MAPK3 | 0.35388958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92239865 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.46073709 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42992216 |
| 4 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.36716231 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.21068350 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13778631 |
| 7 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.13170359 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09610513 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.08588398 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06319335 |
| 11 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 2.05389616 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 1.98093148 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.97023668 |
| 14 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.96001774 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94269537 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89074464 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81068952 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70863679 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.65323227 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62806250 |
| 21 | Colorectal cancer_Homo sapiens_hsa05210 | 1.62678311 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.62065375 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57153220 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.55369876 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54402588 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.54142819 |
| 27 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.53857590 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.53698172 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.52612097 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52125931 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.52062347 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.51342794 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.47848213 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45472672 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43528118 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42495002 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.39477664 |
| 38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.39414415 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.39027688 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35976359 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35719333 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 1.35130718 |
| 43 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.30088597 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29553715 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22867462 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.21726272 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.21024893 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 1.20849499 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19428597 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.18826379 |
| 51 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.16549431 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14685594 |
| 53 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13376184 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11839173 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08961531 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.08556916 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07550346 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06838017 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.05928370 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 1.05221658 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 1.03289066 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.02508512 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 1.00509211 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99322488 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98234185 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98067598 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97492545 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97286906 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.96968492 |
| 70 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96628961 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96246433 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95835274 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.95624966 |
| 74 | Cell cycle_Homo sapiens_hsa04110 | 0.95115719 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93266353 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92847704 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91080610 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90634871 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89843066 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.88859604 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.88375984 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87948491 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87018252 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86485301 |
| 85 | Malaria_Homo sapiens_hsa05144 | 0.85946917 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85653258 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85522473 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85419652 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.84861478 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84481545 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84267189 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83820836 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83175313 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81451208 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81123224 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81036546 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79338576 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77659086 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76918979 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75033177 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74180399 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.73788626 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.73331508 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72948031 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72119122 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72100592 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71751419 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71252387 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69953289 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69318998 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68572112 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68505379 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67975403 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.66644599 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66367244 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66237398 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65926893 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65470535 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64948025 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64391160 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63949681 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62718879 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.62521021 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62224652 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62160148 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61843702 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.60118453 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58728140 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58511357 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58075574 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.57888856 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56492664 |
| 133 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55885916 |
| 134 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55669321 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54981637 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54247427 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53649028 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.52312312 |
| 139 | Shigellosis_Homo sapiens_hsa05131 | 0.51769624 |
| 140 | Spliceosome_Homo sapiens_hsa03040 | 0.51708996 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50570354 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50286601 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50257405 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49658354 |
| 145 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48614580 |
| 146 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48399939 |
| 147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47445729 |
| 148 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46482558 |
| 149 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46263788 |
| 150 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45350201 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45099070 |
| 152 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44915652 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44618787 |
| 154 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43877195 |
| 155 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43780741 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43629825 |
| 157 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43344838 |
| 158 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42539558 |
| 159 | Platelet activation_Homo sapiens_hsa04611 | 0.42203897 |
| 160 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41645915 |
| 161 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41211280 |
| 162 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40665830 |
| 163 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40372191 |
| 164 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40345894 |
| 165 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40226323 |

